Articles

Analysts grill Lilly execs on strategy after setbacks

Wall Street analysts on Thursday demanded to know what new things Eli Lilly and Co. is planning since the company’s vaunted pipeline has failed to produce a drug that will boost revenue after a wave of patent expirations. The answer: Not much.

Read More

FinishMaster reports lower sales, profit

The Indianapolis-based distributor of automotive paints and accessories reported that its second-quarter profit dipped nearly
2 percent, to $3.7 million, from the same period a year earlier.

Read More